Sarepta Therapeutics ( NASDAQ: SRPT) faces an “arduous and treacherous path” to bring its gene therapy Elevidys back to market, according to a STAT report citing a senior FDA official, suggesting the ...

Opendoor Technologies Inc.'s stock soared 470%, driven by hype, not fundamentals. Click for our take on OPEN stock and ...

These five stocks are likely to continue making shareholders wealthy. They dominate their core businesses across the consumer ...

Still a popular over-the-counter option in Russia today, the drug promises to curb anxiety, cure insomnia, manage alcohol ...

UCSF researchers find that two FDA-approved cancer drugs significantly improve memory in Alzheimer’s mouse models and reduce ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead. Shares of Viking ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

We’re cutting through the presuppositional fallacies of financial groupthink and getting down to a specific trading idea for ACI stock.